MagicTouch: Sirolimus Drug Coated Balloon Catheter
Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial | Circulation: Cardiovascular Interventions
Ranger™ - Boston Scientific
C. R. Bard Receives FDA Premarket Approval For The LUTONIX 035 Drug Coated Balloon - Medical Design and Outsourcing
Agentᵀᴹ Drug Coated Eluting Balloon - Boston Scientific
SeQuent® Please OTW
Lepu Medical Vesselin® Drug Eluting Balloon Company, Drug Coated Balloon Coronary
Drug-coated balloon therapy in coronary and peripheral artery disease | Nature Reviews Cardiology
FDA Clears Medtronic Drug-Coated Balloon to Treat Arteriovenous Fistula Lesions | DAIC
In.Pact Admiral Demonstrates Durability, Safety and Efficacy at Three Years | DAIC
Drug-Coated Balloons Expand Treatment Options
Current status, challenges and future directions of drug-eluting balloons | Future Cardiology
Recent FDA Approvals for Drug-eluting Balloons - Drug-eluting Balloons
Current Use of Coronary Drug-Coated Balloons - Cardiac Interventions Today
Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis - ScienceDirect
Drug-coated balloons
Lutonix: Drug Coated Balloons (DCB) for Angioplasties - Lutonix
Drug-Coated Balloon
_1653668541.jpg "Medtronic's In.Pact 018 Drug-Coated Balloon Receives FDA Approval for PAD - Endovascular Today")
Medtronic's In.Pact 018 Drug-Coated Balloon Receives FDA Approval for PAD - Endovascular Today
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group | JACC: Cardiovascular Interventions
IN.PACT Admiral Drug-Coated Balloon Animation - YouTube
Drug-eluting Balloon is Noninferior to Drug-eluting Stent in Patients With In-stent Restenosis | DAIC
Drug-eluting Balloons Enter the U.S. Market | DAIC
